Metal–Catalyst-Free Green and efficient synthesis of five and six membered fused N-heterocyclic quinazoline derivatives

[1]  Satish S. More,et al.  An efficient and convenient protocol for the synthesis of tetracyclic isoindolo[1,2-a]quinazoline derivatives , 2016 .

[2]  Satish P. Nikumbh,et al.  An efficient one pot synthesis of 2-amino quinazolin-4(3H)-one derivative via MCR strategy , 2015 .

[3]  V. Siddaiah,et al.  Sulfonic acid functionalized Wang resin (Wang-OSO3H) as polymeric acidic catalyst for the eco-friendly synthesis of 2,3-dihydroquinazolin-4(1H)-ones , 2015 .

[4]  M. Pal,et al.  A catalyst-free rapid, practical and general synthesis of 2-substituted quinazolin-4(3H)-ones leading to luotonin B and E, bouchardatine and 8-norrutaecarpine , 2015 .

[5]  T. Jayaramudu,et al.  Antibacterial nanocomposite hydrogels for superior biomedical applications: a Facile eco-friendly approach , 2015 .

[6]  M. Pal,et al.  β-Cyclodextrin mediated MCR in water: synthesis of dihydroisoindolo[2,1-a]quinazoline-5,11-dione derivatives under microwave irradiation , 2013 .

[7]  Dipak K. Raval,et al.  Saccharomyces cerevisiae catalyzed one pot synthesis of isoindolo[2,1-a]quinazoline performed under ultrasonication , 2013 .

[8]  Xianqing Deng,et al.  Synthesis and Anticonvulsant Activity Evaluation of 5‐Phenyl‐[1,2,4]triazolo[4,3‐c]quinazolin‐3‐amines , 2013, Archiv der Pharmazie.

[9]  A. Mohanakrishnan,et al.  Oxidative Ring Opening of 1,3‐Diarylbenzo[c]heterocycles Using m‐CPBA: Preparation of 1,2‐Diaroylbenzenes , 2012 .

[10]  G. Schneider,et al.  Structure-activity relationship of nonacidic quinazolinone inhibitors of human microsomal prostaglandin synthase 1 (mPGES 1). , 2012, Journal of medicinal chemistry.

[11]  K. Sashidhara,et al.  Efficient and General Synthesisof 3-Aryl Coumarins Using Cyanuric Chloride , 2012 .

[12]  R. Bunce,et al.  New conditions for synthesis of (±)‐2‐monosubstituted and (±)‐2,2‐disubstituted 2,3‐dihydro‐4(1H)‐quinazolinones from 2‐nitro‐ and 2‐aminobenzamide , 2011 .

[13]  K. Parsa,et al.  A new three-component reaction: green synthesis of novel isoindolo[2,1-a]quinazoline derivatives as potent inhibitors of TNF-α. , 2011, Chemical communications.

[14]  Dave M. Johnson,et al.  Design, synthesis and polymerization of highly branched pseudodendrimers through tandem reactions , 2009 .

[15]  T. Jeong,et al.  Progress in the Studies on Rutaecarpine , 2008, Molecules.

[16]  N. Argade,et al.  The Chemistry of Recently Isolated Naturally Occurring Quinazolinone Alkaloids , 2006 .

[17]  A. Rodomonte,et al.  Synthesis and evaluation as NOP ligands of some spiro[piperidine-4,2'(1'H)-quinazolin]-4'(3'H)-ones and spiro[piperidine-4,5'(6'H)-[1,2,4]triazolo[1,5-c]quinazolines]. , 2006, Chemical & pharmaceutical bulletin.

[18]  M. Poupon,et al.  Synthesis of Methylenedioxy‐Bearing 1‐Aryl‐3‐carboxylisoquinolines Using a Modified Ritter Reaction Procedure. , 2004 .

[19]  Douglas A. Horton,et al.  The combinatorial synthesis of bicyclic privileged structures or privileged substructures. , 2003, Chemical reviews.

[20]  M. Shvekhgeimer Synthesis of Heterocyclic Compounds Based on Isatoic Anhydrides (2H-3,1-Benzoxazine-2,4-diones). (Review) , 2001 .

[21]  Y. Kondo,et al.  Mesityllithium as a reagent for chemoselective halogen-lithium exchange reaction. , 2001, Organic letters.

[22]  P. D. Cook,et al.  Structure-activity relationships of novel 2-substituted quinazoline antibacterial agents. , 1999, Journal of medicinal chemistry.

[23]  K. Wang,et al.  Studies on quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides. 8.1, 2 synthesis and pharmacological evaluation of tricyclic fused quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides as potential alpha1-adrenoceptor antagonists. , 1998, Journal of medicinal chemistry.

[24]  W. Greenlee,et al.  A potent, orally active, balanced affinity angiotensin II AT1 antagonist and AT2 binding inhibitor. , 1993, Journal of medicinal chemistry.

[25]  R. Ferone,et al.  Benzoquinazoline inhibitors of thymidylate synthase: enzyme inhibitory activity and cytotoxicity of some 3-amino- and 3-methylbenzo[f]quinazolin-1(2H)-ones. , 1993, Journal of medicinal chemistry.

[26]  M. Malamas,et al.  Quinazolineacetic acids and related analogues as aldose reductase inhibitors. , 1991, Journal of medicinal chemistry.

[27]  D. Dexter,et al.  Synthesis and biological evaluation of 2-styrylquinazolin-4(3H)-ones, a new class of antimitotic anticancer agents which inhibit tubulin polymerization. , 1990, Journal of medicinal chemistry.

[28]  J. F. Wolfe,et al.  Synthesis and anticonvulsant activity of some new 2-substituted 3-aryl-4(3H)-quinazolinones. , 1990, Journal of medicinal chemistry.